medigraphic.com

2021, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2021; 22 (1)

Investigation of lower limb peripheral artery disease in people over the age of 50

Álvarez PM, Triana MME, Rodríguez VLE, Ramos MLE, Arpajón PY

Language: Spanish
References: 31
Page: 1-14
PDF size: 546.04 Kb.


ABSTRACT

Introduction: Lower limb peripheral artery disease is considered a health problem because it has high rates of morbidity-mortality and non-traumatic amputations. Its presence in adults in the general population is sometimes unknown.
Objective: Assess by investigation the presence of peripheral artery disease of lower limbs in people of the population over 50 years.
Methods: Descriptive and analytical study in 235 people over 50 years from different municipalities of the capital. The diagnosis of arterial disease was made by physical examination and hemodynamic study. Sociodemographic variables and some cardiovascular risk factors were analyzed. The reliability level was of 95%.
Results: Female sex (68.1%), white skin (53.2%) and the age group between 50 and 69 years (68.1%) predominated. There was a higher frequency of the disease in the male sex (70.5%). 55.7% had diabetic macroangiopathy. The prevalences found for peripheral artery disease and risk factors were 51.9% and 91.5%, respectively. 64.7% of people had three or more factors. Hypertension (χ 2 = 23.66; p = 0.0000; OR: 3.88) and obesity (χ 2 = 8,74; p < 0,001; OR: 1,38) were associated with peripheral artery disease.
Conclusions: People over 50 years of age, males and with more than three risk factors have a high risk of developing peripheral lower limb artery disease.


REFERENCES

  1. Aboyans V, Ricco JB, Bartelink MLEL, Björck M, Brodmann M, Cohnert T, et al. Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS). Rev Esp Cardiol. 2018;71(2):111.e1-e69. DOI: https://doi.org/10.1016/j.recesp.2017.12.015

  2. Kullo IJ, Rooke TW. Peripheral artery disease. N Engl J Med. 2016 [acceso 18/07/2020];374(9):861-71. Disponible en: https://mayoclinic.pure.elsevier.com/en/publications/peripheral-artery-disease

  3. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circulation Res. 2015;116(9):1509-26. DOI: https://doi.org/ 10.1161/circresaha.116.303849

  4. Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Williams B, Lisheng L, et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care. 2016 [acceso 18/07/2020]39(10):1796-803. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27456835/

  5. Yamagishi S. Diabetic macrovascular complications. Jpn J Clin Med. 2015 [acceso 18/07/2020];73(3):479-83. Disponible en: https://scholar.google.com.cu/scholar?q=Yamagishi+S.+Diabetic+macrovascular+complication

  6. Poznya A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, et al. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int. J. Mol. Sci. 2020;21(5):1835. DOI: https://doi.org/10.3390/ijms21051835

  7. Fernández JI. Angiopatía Diabética. En: Pérez Rovira M del C, Linares F, eds. Angiología y Cirugía Vascular. La Habana: Editorial Ciencias Médicas;1988. p. 207-17.

  8. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41:255-323. DOI: https://doi.org/10.1093/eurheartj/ehz486

  9. Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, et al. BARI 2D Study group. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 Diabetes (BARI 2D) trial. Diabetes Care. 2014 [acceso 22/07/2020]37(5):1346-52. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24595631/

  10. L. Norgren. Commentary onPeripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population Based Cohort. The REGICOR Study Eur J Vasc Endovasc Surg. 2016 [acceso 20/07/2020];34:1951-71. Disponible en: https://www.ejves.com/article/S1078-5884(16)00038-1/pdf

  11. Guo X, Li J, Pang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circulation J. 2008 [acceso 22/07/2020]72(4):605-10. Disponible en: https://www.jstage.jst.go.jp/article/circj/72/4/72_4_605/_article/-char/en

  12. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969;56:676-9.

  13. Apovian CM, Aronne LJ. The 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity. 2013; 132:1586-91. DOI: https://doi.org/10.1161/circulationaha.114.010772

  14. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension. Global hypertension practice guidelines. Hypertension. 2020;75:1334-57. DOI: https://doi.org/10.1161/hypertensionaha.120.15026

  15. Mach F, Colin Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020 Jan;41(1):111-88. DOI: https://doi.org/10.1093/eurheartj/ehz455

  16. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico 2019. La Habana: MINSAP; 2020 [acceso 03/05/2020]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/año,2020

  17. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-40. DOI: https://doi.org/10.1016/S0140-6736(13)61249-0

  18. Peter WF, Wilson P, Gagnon D. Diabetes mellitus and control of cardiovascular disease risk factors: A challenge to improve usual care. Circulation. 2017;136(13):1204-6. DOI: https://doi.org/10.1161/circulationaha.117.029839

  19. De la Torre Puente C, Triana Mantilla ME, Rodríguez Villalonga LE, Arpajón Peña Y, Almeida Hernández L, Martínez Góngora I. Enfermedades vasculares periféricas y niveles de calidad de vida en el municipio Diez de Octubre. Rev Cubana Angiol y Cir Vasc. 2017 [acceso 27/01/2020];18(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol18_1_17/ang06117.htm

  20. González Casanova JM, Valdés Chávez RC, Álvarez Gómez AE, Toirac Delgado K, Casanova Moreno MC. Factores de riesgo de aterosclerosis en adultos mayores diabéticos de un consultorio médico. Rev Univ Méd Pinareña. 2018 [acceso 18/02/2020];14(2):121-8. Disponible en: https://www.medigraphic.com/pdfs/revunimedpin/ump-2018/ump182e.pdf

  21. Santana López S, Montero Díaz R, Sánchez Fuentes AL, Valdés Vento AC, Vidal Vega IC. Caracterización de los factores de riesgo de la aterosclerosis. Rev Ciencias Médicas. 2016 [acceso 18/01/2020];20(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942016000100025&lng=es

  22. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308:1660-7. DOI: https://doi.org/10.1001/jama.2012.13415

  23. Carter BD, Abnet CC, Feskanich D. Smoking and mortality: beyond established causes. N Engl J Med. 2015 [acceso 20/02/2020]372:631-40. Disponible en: https://europepmc.org/article/med/25671255

  24. Rentería E, Jha P, Forman D, Soerjomataram I. The impact of cigarette smoking on life expectancy between 1980 and 2010: a global perspective. Tob Control. 2016 [acceso 20/02/2020]25:551-57. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26307052/

  25. Muredach P Reilly. Tobacco-related cardiovascular diseases in the 21st Century. Arterioscl Throm Vasc Biol. 2013 Jul [aceso 01/03/2020]33(7):1458-9. Disponible en: https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.113.301632

  26. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of Disease Study 2015. The Lancet. 2017;1-22. DOI: http://dx.doi.org/10.1016/S0140-6736(17)30819-X

  27. Thompson RC, Allam AH, Lombardi GP, Wann LS, Sutherland ML, James D, Sutherland JD, et al. Atherosclerosis across 4000 years of human history: the horus study of four ancient populations. The Lancet. 2013:1-12. DOI: http://dx.doi.org/10.1016/S0140-6736(13)60598-X

  28. Hong Lu, Daugherty A. Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(3):485-91. DOI: http://dx.doi.org/10.1161/ATVBAHA.115.305380

  29. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017 [acceso 01/03/2020]38:2459-72. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837225/

  30. Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, et al. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA. 2019 [acceso 19/02/2020]321:364-73. Disponible en: https://europepmc.org/article/pmc/pmc6439767

  31. Álvarez Prats M, Triana Mantilla ME, Rodríguez Villalonga LE, Torres Reyes X. Perfil lipídico mínimo para el diagnóstico del riesgo de enfermedad vascular periférica de los miembros inferiores. Rev Cubana Angiol y Cir Vasc. 2019 [acceso 19/02/2020];20(3). Disponible en: http://revangiologia.sld.cu/index.php/ang/article/view/56/108




2020     |     www.medigraphic.com